|
Characteristics
| | | |
|
Recipient gender (male)
|
105 (71%)
|
59 (71%)
|
ns
|
|
Recipient age (years); median (range)
|
64.5 (14.9 to 82.8)
|
65.8 (32.1 to 80.5)
|
ns
|
|
Donor gender (male)
|
100 (67%)
|
38 (46%)
|
0.002
|
|
Donor age (years); median (range)
|
67.6 (60.2 to 89.0)
|
65.5 (60.3 to 78.8)
|
0.03
|
|
Time on dialysis (years); median (range)
|
1.5 (0.0 to 6.3)
|
1.4 (0.0 to 5.9)
|
ns
|
|
Diabetic nephropathy
|
14 (9%)
|
8 (10%)
|
ns
|
|
Vascular nephropathy
|
40 (27%)
|
32 (38%)
|
ns
|
|
PRA positive recipients
|
10 (7%)
|
4 (5%)
|
ns
|
|
Any HLA-A mismatch
|
122 (82%)
|
62 (75%)
|
ns
|
|
Any HLA-B mismatch
|
130 (87%)
|
78 (94%)
|
ns
|
|
Any HLA-DR mismatch
|
82 (55%)
|
41 (49%)
|
ns
|
|
CMV-positive recipient
|
125 (84%)
|
57 (69%)
|
0.01
|
|
CMV-positive donor
|
121 (82%)
|
72 (87%)
|
ns
|
|
Cold ischemia time (hours); mean ± SD
|
14.4 ± 5.1
|
13.3 ± 4.9
|
ns
|
|
Transplant year
| | | |
|
2004
|
0
|
24
| |
|
2005
|
6
|
26
| |
|
2006
|
6
|
26
| |
|
2007
|
43
|
6
| |
|
2008
|
46
|
0
| |
|
2009
|
48
|
1
| |
|
Initial CNI
| | | |
|
CsA
|
126 (85%)
|
80 (96%)
|
0.008
|
|
Tacrolimus
|
23 (15%)
|
3 (4%)
|
0.008
|
|
PRA, panel-reactive antibodies
| | | |
